- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by C2i Genomics
Total 1035 results
-
Translational Genomics Research InstituteUnited States Department of DefenseCompleted
-
Genomics PLCNHS North of England Commissioning Support (NECS)CompletedCardiovascular DiseasesUnited Kingdom
-
University of California, San FranciscoTranslational Genomics Research InstituteCompletedDiffuse Intrinsic Pontine Glioma (DIPG)United States
-
Singlera Genomics Inc.The First Hospital of Jilin UniversityRecruitingHepatocellular CarcinomaChina
-
Coral Genomics, Inc.National Human Genome Research Institute (NHGRI)TerminatedRheumatoid Arthritis | Psoriasis | Crohn's Disease | Ulcerative ColitisUnited States
-
CTI BioPharmaCompletedAcute Myelogenous LeukemiaUnited States
-
CTI BioPharmaCompletedDiffuse Large B-cell Lymphoma | de Novo DLBCL | DLBCL Transformed From Indolent Lymphoma | Follicular Grade 3 LymphomaUnited States, Germany, Italy, United Kingdom, Hungary, France, Spain, Ukraine, Czechia, Austria, Belgium, Bulgaria, Denmark, Poland, Romania, Russian Federation, Slovakia
-
CTI BioPharmaTerminatedNSCLCUnited States, Canada, Bulgaria, Romania, Russian Federation, Ukraine, Mexico, Argentina, Hungary, Poland, United Kingdom
-
CTI BioPharmaTerminatedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Australia, Belgium, Czechia, France, Germany, Hungary, Italy, Netherlands, New Zealand, Russian Federation, United Kingdom
-
CVI PharmaceuticalsUnknown
-
C2N DiagnosticsCompletedProgressive Supranuclear PalsyUnited States
-
CTI BioPharmaCompletedDiffuse Large-Cell LymphomaUnited States, Germany, Canada, Italy, France
-
Bionano GenomicsColumbia University; University of Iowa; Medical College of Wisconsin; Augusta... and other collaboratorsRecruitingIntellectual Disability | Autism Spectrum Disorder | Fragile X Syndrome | Developmental Disability | Congenital Anomaly | Facioscapulohumeral Muscular Dystrophy 1United States
-
ReCode TherapeuticsSano Genetics; ReverbaRecruitingPrimary Ciliary DyskinesiaUnited States
-
Neuracle Genetics, IncORA, Inc.RecruitingAge-Related Macular DegenerationCanada
-
NewLink Genetics CorporationCompletedMetastatic Melanoma | Stage IV Melanoma | Stage III MelanomaUnited States
-
NewLink Genetics CorporationCompleted
-
NewLink Genetics CorporationTerminatedMelanoma | Breast Cancer | Pancreatic Cancer | Lung Cancer | Solid TumorsUnited States
-
NewLink Genetics CorporationCompleted
-
NewLink Genetics CorporationTerminatedPancreatic Cancer | Pancreatic Carcinoma Non-resectableUnited States
-
NewLink Genetics CorporationTerminatedPancreatic Cancer | Locally Advanced Malignant Neoplasm | Pancreatic Carcinoma Non-resectableUnited States
-
NewLink Genetics CorporationTerminated
-
NewLink Genetics CorporationCompleted
-
NewLink Genetics CorporationCompletedCancer | Solid TumorUnited States
-
NewLink Genetics CorporationTerminatedNon-small Cell Lung Cancer | Non-small Cell Lung Cancer Recurrent | Progression of Non-small Cell Lung CancerUnited States
-
CTI BioPharmaWithdrawnMetastatic CancerUnited States
-
C2N DiagnosticsCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive DeclineUnited States
-
CTI BioPharmaCompletedPrimary Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | Post- Essential Thrombocythemia MyelofibrosisUnited States, Spain, United Kingdom, Hungary, Korea, Republic of, France, Italy, Sweden
-
CTI BioPharmaWithdrawnLymphoma | LeukemiaUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminated
-
CTI BioPharmaCompletedLymphoma, Non-HodgkinUnited States, United Kingdom, France, Italy, India, Germany, Hungary, Argentina, Uruguay, Russian Federation, Bulgaria, Costa Rica, Ecuador, Estonia, Mexico, Panama, Peru, Poland, Romania, Ukraine
-
CTI BioPharmaWithdrawnLymphoma | Solid Tumor (Excluding CNS)United States
-
CTI BioPharmaCompletedLymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-Grade | Lymphoma, Small LymphocyticUnited States
-
CTI BioPharmaCompletedOvarian CancerFrance, United Kingdom, Italy
-
C2N DiagnosticsRecruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Memory ImpairmentUnited States
-
CTI BioPharmaTerminatedCOVID-19 | COVID | COVID19United States
-
CTI BioPharmaTerminatedPrimary Myelofibrosis | Post-polycythemia Vera Myelofibrosis | Post-essential Thrombocythemia MyelofibrosisUnited States, Canada, France, United Kingdom, Australia, Belgium, Germany, New Zealand, Netherlands, Russian Federation, Hungary, Czechia
-
CTI BioPharmaTerminatedProstate CancerUnited States
-
CTI BioPharmaWithdrawn
-
CTI BioPharmaWithdrawnNon-Hodgkin's LymphomaUnited States
-
CTI BioPharmaTerminated
-
CTI BioPharmaTerminatedLymphoma, Follicular | Lymphoma, Mixed-Cell, Follicular | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Low-GradeUnited States
-
CLI FoundationUnknownST-elevation Myocardial InfarctionItaly
-
CTI BioPharmaCompleted
-
Berry Genomics Co., Ltd.Shanghai Chest Hospital; Baotou Cancer HospitalUnknownAdenocarcinoma | Nonsmall Cell Lung CancerChina
-
Mercer UniversityMerck Sharp & Dohme LLC; Emory University; Celera GenomicsCompletedType 2 Diabetes | Cholesterol | African American | Lipoprotein | ApolipoproteinUnited States